NEW: AstraZeneca provided an “incomplete view of efficacy data” on COVID-19 vaccine from a large scale U.S. trial, according to the National Institute of Allergy and Infectious Diseases (NIAID) - Conspiracies

Conspiracies

Communities Topics

Hot

All Posts

DEFAULT COMMUNITIES • All General AskWin Funny Technology Animals Sports Gaming DIY Health Positive Privacy

NEW: AstraZeneca provided an “incomplete view of efficacy data” on COVID-19 vaccine from a large scale U.S. trial, according to the National Institute of Allergy and Infectious Diseases (NIAID) (twitter.com)

posted 3 years ago by axolotl_peyotl 3 years ago by axolotl_peyotl +21 / -1

4 comments

4 comments share save hide report block hide replies

You're viewing a single comment thread. View all comments, or full comment thread.

Comments (4)

sorted by:

▲ 2 ▼

– FrostedCricketFlakes 2 points 3 years ago +2 / -0

And they would know, they paid for the Wuhan Lab's Gain of Function research.

permalink save report block reply

GIFs

Conspiracies Wiki & Links

Conspiracies Book List

External Digital Book Libraries

Mod Logs

Honor Roll

Conspiracies.win: This is a forum for free thinking and for discussing issues which have captured your imagination. Please respect other views and opinions, and keep an open mind. Our goal is to create a fairer and more transparent world for a better future.

Community Rules: <click this link for a detailed explanation of the rules

Rule 1: Be respectful. Attack the argument, not the person.

Rule 2: Don't abuse the report function.

Rule 3: No excessive, unnecessary and/or bullying "meta" posts.

To prevent SPAM, posts from accounts younger than 4 days old, and/or with <50 points, wont appear in the feed until approved by a mod.

Disclaimer: Submissions/comments of exceptionally low quality, trolling, stalking, spam, and those submissions/comments determined to be intentionally misleading, calls to violence and/or abuse of other users here, may all be removed at moderator's discretion.

Moderators

Message the Moderators

2024.12.01 - gwld8 (status)